Company Overview
Snapshot
Founded in July 1975 by Zvulun Tomer, Unipharm operates with 51–200 employees. The company specializes in the development, manufacturing, and marketing of generic pharmaceuticals, leveraging its EU-GMP-certified manufacturing plant in Israel.
Business overview
Unipharm develops, manufactures, and markets a broad portfolio of high-quality generic pharmaceuticals. The company's product offerings span major therapeutic areas including mental health, heart health, sleep disorders, Alzheimer's disease, osteoporosis, infectious diseases, urology, and ophthalmology. Unipharm serves global markets including Europe, Central America, Israel, Southeast Asia, North America, and South America, operating within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
Log in to access full profile ›Company Intelligence Q&A
- When was Unipharm founded and by whom?
- Unipharm was founded in July 1975 by Zvulun Tomer.
- What is Unipharm's primary business activity?
- Unipharm develops, manufactures, and markets generic pharmaceuticals across various therapeutic areas.
- What therapeutic areas does Unipharm's product portfolio cover?
- Unipharm's product portfolio covers mental health, heart health, sleep drugs, Alzheimer's disease, osteoporosis, infectious diseases, urology, and ophthalmology.
- Where are Unipharm's drugs manufactured?
- Unipharm's drugs are manufactured at its EU-GMP-certified facility located in Mavo Carmel Industrial Park, Israel.
- In which geographic markets does Unipharm operate?
- Unipharm operates in Europe, Central America, Israel, Southeast Asia, North America, and South America.